COMPASS Pathways
CMPS
11.69
+0.13
+1.12%
COMPASS Pathways
US · CMPS
#2952 by market cap
Listed 2020
11.69
+0.13
+1.12%
Live - 5344 symbols - heartbeat 363s ago
· 2026-10-08 07:31
Pre-market
11.75
+0.51%
After-hours
11.89
+1.71%
Overnight
11.91
+1.88%
- Market cap
- 1.62B
- P/E (TTM)i
- -3.08
- P/Bi
- 19.16
- EPSi
- -3.08
- Div yieldi
- 0.00%
- 52W posi
- 62%
Reader sentiment
Are you bullish or bearish on CMPS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.7 percentage points.
Institutional ownership
- Held by institutions
- 69.90% -2.68pp
- Institutions
- 238 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Hedge Fund30.69%
Mutual Fund19.26%
VC/PE Fund10.88%
Public Company6.95%
Private Company1.87%
Individual/Insider1.64%
Endowment Fund0.15%
Other28.46%
Top holders as of 2026-06-30
Deep Track Capital, LP
8.78% · 12.16M sh
RTW Investments, LP
7.73% · 10.70M sh
BIT Capital GmbH
4.58% · 6.35M sh
Tang Capital Management, LLC
3.61% · 5.00M sh
Eli Lilly and Company
3.44% · 4.76M sh
Two Sigma Investments, LP
3.23% · 4.47M sh
Marshall Wace LLP
3.13% · 4.33M sh
ARK Investment Management LLC
2.49% · 3.45M sh
Point72 Asset Management, L.P.
1.89% · 2.62M sh
Logos Global Management, L.P.
1.62% · 2.25M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 33 buys · 17 sells
| Name | Role | Stake |
|---|---|---|
| George Goldsmith | Chairman & Co-founder | 1.48% |
| Thomas Lonngren | Independent Non-Executive Director | 0.06% |
| Kabir Nath | Chief Executive Officer | 0.05% |
| Teri Loxam | CFO, Principal Financial Officer & Principal Accounting Officer | 0.02% |
| David Norton | Lead Independent Director | 0.01% |
| Annalisa Lisa Jenkins | Independent Non-Executive Director | 0.01% |
| Guy Goodwin | Chief Medical Officer | 0.00% |
| Jeffrey Jonas | Director | -- |
| Justin Gover | Director | -- |
| Linda McGoldrick | Independent Non-Executive Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-09 | Annalisa Lisa Jenkins | Independent Non-Executive Director | Intent to Sell (Form 144) | -26,000 | $13.30 |
| 2026-08-06 | Annalisa Lisa Jenkins | Independent Non-Executive Director | Intent to Sell (Form 144) | -83,771 | $13.72 |
| 2026-08-02 | Kabir Nath | Chief Executive Officer | Sale to Issuer | -5,962 | $11.25 |
| 2026-05-26 | Jeffrey Jonas | Director | Other Derivative Acquisition | +21,110 | $11.85 |
| 2026-05-26 | Justin Gover | Director | Other Derivative Acquisition | +21,110 | $11.85 |
| 2026-05-26 | Gino Santini | Chairperson | Other Derivative Acquisition | +30,158 | $11.85 |
| 2026-05-26 | David Norton | Lead Independent Director | Other Derivative Acquisition | +21,110 | $11.85 |
| 2026-05-26 | Daphne Karydas | Independent Director | Other Derivative Acquisition | +21,110 | $11.85 |
| 2026-05-26 | Robert McQuade | Independent Non-Executive Director | Other Derivative Acquisition | +21,110 | $11.85 |
| 2026-05-26 | Wayne Riley | Independent Non-Executive Director | Other Derivative Acquisition | +21,110 | $11.85 |
| 2026-05-26 | Kathleen Tregoning | Director | Other Derivative Acquisition | +41,119 | $11.85 |
| 2026-03-25 | Teri Loxam | CFO, Principal Financial Officer & Principal Accounting Officer | Other Acquisition | +75,000 | -- |
| 2026-03-25 | Teri Loxam | CFO, Principal Financial Officer & Principal Accounting Officer | Other Derivative Acquisition | +157,635 | $5.64 |
| 2026-03-25 | Kabir Nath | Chief Executive Officer | Other Acquisition | +175,000 | -- |
| 2026-03-25 | Kabir Nath | Chief Executive Officer | Other Derivative Acquisition | +367,815 | $5.64 |
| 2026-03-25 | Guy Goodwin | Chief Medical Officer | Other Derivative Acquisition | +170,600 | $0.01–5.64 |
| 2026-03-10 | Teri Loxam | CFO, Principal Financial Officer & Principal Accounting Officer | Sale to Issuer | -1,781 | $6.89 |
| 2026-03-10 | Kabir Nath | Chief Executive Officer | Sale to Issuer | -13,131 | $6.89 |
| 2026-03-01 | Teri Loxam | CFO, Principal Financial Officer & Principal Accounting Officer | Sale to Issuer | -4,467 | $7.02 |
| 2026-02-01 | Kabir Nath | Chief Executive Officer | Sale to Issuer | -16,181 | $6.61 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:31:01 · For reference only, not investment advice and not tailored to your situation.